GPI 15427

Known as: GPI-15427, GPI15427 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2012
01220032012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Poly(ADP-ribose) polymerase (PARP) inhibitors have neuroprotective effects after retinal ischemia and reperfusion (I/R) injury… (More)
Is this relevant?
2011
2011
Poly(ADP-ribose) polymerase (PARP) activation has been implicated in the pathogenesis of diabetic complications, including… (More)
  • table I
  • table II
  • table III
  • figure 1
  • figure 2
Is this relevant?
2010
2010
BACKGROUND In this study, we tested the ability of a novel poly(adenosine diphosphate ribose) polymerase (PARP) inhibitor, 10-(4… (More)
Is this relevant?
2009
2009
PURPOSE This study evaluated the role for poly(ADP-ribose) polymerase (PARP) in diabetes-induced cataractogenesis and early… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
This study was aimed at evaluating the role for poly(ADP-ribose) polymerase (PARP) in early nephropathy associated with type 1… (More)
Is this relevant?
2008
2008
Evidence that poly(ADP-ribose) polymerase (PARP) activation plays an important role in diabetic complications is emerging. This… (More)
Is this relevant?
2006
2006
Poly(ADP-ribose) polymerase (PARP) inhibitors enhance the antitumor activity of the topoisomerase I inhibitor irinotecan (CPT-11… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
2005
2005
Poly (ADP-ribose) polymerase-1 (PARP-1), a nuclear enzyme activated by DNA strand breaks, plays a detrimental role during… (More)
Is this relevant?
2005
2005
We previously demonstrated that intravenous or intra-cerebral administration of poly (ADP-ribose) polymerase-1 (PARP-1… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE Temozolomide (TMZ) is a DNA methylating agent that has shown promising antitumor activity in recent clinical trials… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?